| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Stolarski Anthony Michael | Director | 11495 VALLEY VIEW ROAD, EDEN PRAIRIE | /s/ Griffin D. Foster as Attorney-in-Fact for Anthony Michael Stolarski | 2025-06-12 | 0001683425 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SNWV | Common Stock | Conversion of derivative security | $1.55M | +103K | +227.33% | $15.00 | 148K | Aug 5, 2023 | Direct | F1 |
| transaction | SNWV | Common Stock | Conversion of derivative security | $104K | +6.9K | +4.65% | $15.00 | 155K | Nov 14, 2023 | Direct | F2 |
| transaction | SNWV | Common Stock | Award | +80.7K | +51.94% | 236K | Oct 18, 2024 | Direct | F3 | ||
| transaction | SNWV | Common Stock | Award | +76.2K | +32.28% | 312K | Oct 18, 2024 | Direct | F3 | ||
| transaction | SNWV | Common Stock | Award | +5.4K | +1.73% | 318K | Oct 18, 2024 | Direct | F3 | ||
| transaction | SNWV | Common Stock | Award | +5.1K | +1.61% | 323K | Oct 18, 2024 | Direct | F3 | ||
| transaction | SNWV | Common Stock | Award | +11.5K | +3.56% | 334K | Oct 18, 2024 | Direct | F3 | ||
| transaction | SNWV | Common Stock | Award | +9K | +2.69% | 343K | Oct 18, 2024 | Direct | F3 | ||
| transaction | SNWV | Common Stock | Award | +8.5K | +2.48% | 352K | Oct 18, 2024 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SNWV | Class O Warrant (right to buy) | Disposed to Issuer | $0 | -533 | -100% | $0.00 | 0 | Mar 1, 2019 | Common Stock | 533 | $41.25 | Direct | F4 |
| transaction | SNWV | Class O Warrant (right to buy) | Award | $0 | +533 | $0.00 | 533 | Mar 1, 2019 | Common Stock | 533 | $41.25 | Direct | F4 | |
| transaction | SNWV | Class O Warrant (right to buy) | Disposed to Issuer | $0 | -533 | -100% | $0.00 | 0 | May 31, 2019 | Common Stock | 533 | $41.25 | Direct | F5 |
| transaction | SNWV | Class O Warrant (right to buy) | Award | $0 | +533 | $0.00 | 533 | May 31, 2019 | Common Stock | 533 | $41.25 | Direct | F5 | |
| transaction | SNWV | Future Advance Convertible Promissory Note | Award | $1.34M | $1.34M | Aug 5, 2022 | Common Stock | 89.7K | $15.00 | Direct | F6 | |||
| transaction | SNWV | Future Advance Convertible Promissory Note | Conversion of derivative security | -$1.55M | 0 | Aug 5, 2023 | Common Stock | 103K | $15.00 | Direct | F1 | |||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Award | +89.7K | 89.7K | Aug 5, 2022 | Common Stock | 89.7K | $15.00 | Direct | F6 | |||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Disposed to Issuer | -89.7K | -100% | 0 | Oct 18, 2024 | Common Stock | 89.7K | $15.00 | Direct | F3 | ||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Award | +89.7K | 89.7K | Aug 5, 2022 | Common Stock | 89.7K | $25.13 | Direct | F6 | |||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Disposed to Issuer | -89.7K | -100% | 0 | Oct 18, 2024 | Common Stock | 89.7K | $25.13 | Direct | F3 | ||
| transaction | SNWV | Future Advance Convertible Promissory Note | Award | $90K | $90K | Nov 14, 2022 | Common Stock | 6K | $15.00 | Direct | F7 | |||
| transaction | SNWV | Future Advance Convertible Promissory Note | Conversion of derivative security | -$104K | 0 | Nov 14, 2023 | Common Stock | 6.9K | $15.00 | Direct | F2 | |||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Award | +6K | 6K | Nov 14, 2022 | Common Stock | 6K | $15.00 | Direct | F7 | |||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Disposed to Issuer | -6K | -100% | 0 | Oct 18, 2024 | Common Stock | 6K | $15.00 | Direct | F3 | ||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Award | +6K | 6K | Nov 14, 2022 | Common Stock | 6K | $25.13 | Direct | F7 | |||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Disposed to Issuer | -6K | -100% | 0 | Oct 18, 2024 | Common Stock | 6K | $25.13 | Direct | F3 | ||
| transaction | SNWV | Asset-Backed Secured Promissory Note | Award | $150K | $150K | Jul 21, 2023 | Common Stock | $150K | Direct | F8 | ||||
| transaction | SNWV | Asset-Backed Secured Promissory Note | Disposed to Issuer | -$150K | $0 | Jan 21, 2024 | Common Stock | $150K | Direct | F8 | ||||
| transaction | SNWV | Future Advance Convertible Promissory Note | Award | $150K | $150K | Jan 21, 2024 | Common Stock | 10K | $15.00 | Direct | F8 | |||
| transaction | SNWV | Future Advance Convertible Promissory Note | Disposed to Issuer | -$172K | 0 | Oct 18, 2024 | Common Stock | 11.5K | $15.00 | Direct | F3 | |||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Award | +10K | 10K | Jan 21, 2024 | Common Stock | 10K | $15.00 | Direct | F8 | |||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Disposed to Issuer | -10K | -100% | 0 | Oct 18, 2024 | Common Stock | 10K | $15.00 | Direct | F3 | ||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Award | +10K | 10K | Jan 21, 2024 | Common Stock | 10K | $25.13 | Direct | F8 | |||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Disposed to Issuer | -10K | -100% | 0 | Oct 18, 2024 | Common Stock | 10K | $25.13 | Direct | F3 | ||
| transaction | SNWV | Stock Option (right to buy) | Award | $0 | +41.3K | $0.00 | 41.3K | Oct 22, 2024 | Common Stock | 41.3K | $14.20 | Direct | F9 | |
| transaction | SNWV | Stock Option (right to buy) | Award | $0 | +1.56K | $0.00 | 1.56K | Dec 31, 2024 | Common Stock | 1.56K | $22.76 | Direct | F10 | |
| transaction | SNWV | Stock Option (right to buy) | Award | $0 | +1.76K | $0.00 | 1.76K | Apr 3, 2025 | Common Stock | 1.76K | $29.80 | Direct | F10 |
Anthony Michael Stolarski is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | Pursuant to the terms of the Future Advance Convertible Promissory Note issued by SANUWAVE Health, Inc. (the "Company") on August 5, 2022, all principal and accrued interest due as of the maturity date, August 5, 2023, was automatically converted into shares of common stock at a conversion price of $15.00 per share. |
| F2 | Pursuant to the terms of the Future Advance Convertible Promissory Note issued by the Company on November 14, 2022, all principal and accrued interest due as of the maturity date, November 14, 2023, was automatically converted into shares of common stock at a conversion price of $15.00 per share. |
| F3 | On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| F4 | On March 1, 2019, the Company extended the expiration date of the Class O Warrants to June 28, 2019. |
| F5 | On May 31, 2019, the Company extended the expiration date of the Class O Warrants to September 3, 2019. |
| F6 | On August 5, 2022, in exchange for the discharge of $1,344,966 owed by the Company to the reporting person, the reporting person acquired from the Company a Future Advance Convertible Promissory Note with a principal amount of $1,344,966 and a conversion price of $15.00 per share of common stock and two warrants (one exercisable for 89,664 shares of common stock at an exercise price of $15.00 per share and the other exercisable for 89,664 shares of common stock at an exercise price of approximately $25.13 per share). |
| F7 | On November 14, 2022, in exchange for $90,000 in cash, the reporting person acquired from the Company a Future Advance Convertible Promissory Note with a principal amount of $90,000 and a conversion price of $15.00 per share of common stock and two warrants (one exercisable for 6,000 shares of common stock at an exercise price of $15.00 per share and the other exercisable for 6,000 shares of common stock at an exercise price of approximately $25.13 per share). |
| F8 | On July 21, 2023, in exchange for $100,000 in cash, the reporting person acquired from the Company an Asset-Backed Secured Promissory Note with a principal amount of $149,992.50. Pursuant to a letter agreement between the Company and the reporting person, dated as of July 21, 2023, the Company agreed to issue to the reporting person on January 21, 2024 a Future Advance Convertible Promissory Note with a principal amount of $149,992.50 and two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, each of which were exercisable for 9,999 shares of common stock. |
| F9 | Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date. |
| F10 | Options were fully vested at the grant date. |
All share amounts, exercise prices and conversion prices herein have been retroactively adjusted to reflect the 1-for-375 reverse stock split of the Company's common stock which occurred on October 18, 2024.